Suppr超能文献

急性间歇性卟啉病红细胞中的尿卟啉原合酶:新的病理生化方面(作者译)

[Uroporphyrinogen synthase in erythrocytes in acute intermittent porphyria: new pathobiochemical aspects (author's transl)].

作者信息

Doss M, von Tiepermann R

出版信息

J Clin Chem Clin Biochem. 1978 Feb;16(2):111-8.

PMID:624910
Abstract

Uroporphyrinogen synthase (EC 4.3.1.8) was determined in the erythrocytes of 380 patients, of which 21 showed clinical symptoms of acute intermittent porphyria. The normal range of a random sample was 61 +/- 23 mumol/1.h(x +/- 2s, n=302), including the activity of uroporphyrinogen cosynthase and the subsequent enzymes; when all the latter enzymes were destroyed by heating the haemolysate, the normal range for uroporphyrinogen synthase was 65 +/- 25 mumol/1.h(x +/- 2s, n=274). The respective activity of uroporphyrinogen synthase in patients with acute intermittent porphyria was 35 +/- 12, and 40 +/- 18 mumol/1.h which was significantly lower (p less than 0.001) than the control values. In the 21 cases of acute intermittent porphyria, the diagnosis had already been made from the presence of porphyrin precursors and porphyrin in the urine. In 7 of the 21 cases of acute intermittent porphyria, and in 6 relatives of the patients, the activity of the uroporphyrinogen synthase was in the overlap zone (40-50 mumol/1.h). 32 relatives of 9 of the patients with acute intermittent porphyria were investigated: 22 showed a significant decrease of uroporphyrinogen synthase, and 7 of these showed pathological urinary porphyrin precursors and porphyrin. The relative activity of uroporphyrinogen synthase in patients with acute intermittent porphyria was 57%. A decrease of the uroporphyrinogen synthase activity of greater than 30% compared with the mean of the controls is a sure indicator for the presence of a primary enzymic defect in the gene carrier for acute intermittent porphyria.

摘要

对380例患者的红细胞进行了尿卟啉原合酶(EC 4.3.1.8)测定,其中21例有急性间歇性卟啉病的临床症状。随机抽取的302例样本的正常范围是61±23μmol/1.h(x±2s),包括尿卟啉原辅酶合酶及后续酶的活性;当通过加热溶血产物破坏所有后续酶时,尿卟啉原合酶的正常范围是65±25μmol/1.h(x±2s,n=274)。急性间歇性卟啉病患者尿卟啉原合酶的各自活性分别为35±12和40±18μmol/1.h,显著低于对照值(p<0.001)。在21例急性间歇性卟啉病患者中,诊断已根据尿中卟啉前体和卟啉的存在做出。在21例急性间歇性卟啉病患者中的7例以及患者的6名亲属中,尿卟啉原合酶活性处于重叠区(40 - 50μmol/1.h)。对9例急性间歇性卟啉病患者的32名亲属进行了调查:22例显示尿卟啉原合酶显著降低,其中7例显示病理性尿卟啉前体和卟啉。急性间歇性卟啉病患者尿卟啉原合酶的相对活性为57%。与对照组平均值相比,尿卟啉原合酶活性降低超过30%是急性间歇性卟啉病基因携带者存在原发性酶缺陷的可靠指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验